317 related articles for article (PubMed ID: 34366346)
21. Expression of the Alzheimer's Disease Mutations AβPP695sw and PSEN1M146I in Double-Transgenic Göttingen Minipigs.
Jakobsen JE; Johansen MG; Schmidt M; Liu Y; Li R; Callesen H; Melnikova M; Habekost M; Matrone C; Bouter Y; Bayer TA; Nielsen AL; Duthie M; Fraser PE; Holm IE; Jørgensen AL
J Alzheimers Dis; 2016 Jul; 53(4):1617-30. PubMed ID: 27540966
[TBL] [Abstract][Full Text] [Related]
22. BACE1 Overexpression Reduces SH-SY5Y Cell Viability Through a Mechanism Distinct from Amyloid-β Peptide Accumulation: Beta Prime-Mediated Competitive Depletion of sAβPPα.
Owens L; Bracewell J; Benedetto A; Dawson N; Gaffney C; Parkin E
J Alzheimers Dis; 2022; 86(3):1201-1220. PubMed ID: 35180123
[TBL] [Abstract][Full Text] [Related]
23. Different Expression Patterns of Amyloid-β Protein Precursor Secretases in Human and Mouse Hippocampal Neurons: A Potential Contribution to Species Differences in Neuronal Susceptibility to Amyloid-β Pathogenesis.
Xu ZQ; Huang H; Chen YL; Gao YY; Xu J; Marshall C; Cai ZY; Xiao M
J Alzheimers Dis; 2016; 51(1):179-95. PubMed ID: 26836155
[TBL] [Abstract][Full Text] [Related]
24. Brain pyroglutamate amyloid-β is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer's disease therapeutic.
Hook G; Yu J; Toneff T; Kindy M; Hook V
J Alzheimers Dis; 2014; 41(1):129-49. PubMed ID: 24595198
[TBL] [Abstract][Full Text] [Related]
25. Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?
Dunys J; Valverde A; Checler F
J Biol Chem; 2018 Oct; 293(40):15419-15428. PubMed ID: 30143530
[TBL] [Abstract][Full Text] [Related]
26. Coenzyme Q10 decreases amyloid pathology and improves behavior in a transgenic mouse model of Alzheimer's disease.
Dumont M; Kipiani K; Yu F; Wille E; Katz M; Calingasan NY; Gouras GK; Lin MT; Beal MF
J Alzheimers Dis; 2011; 27(1):211-23. PubMed ID: 21799249
[TBL] [Abstract][Full Text] [Related]
27. Carnosic acid suppresses the production of amyloid-β 1-42 by inducing the metalloprotease gene TACE/ADAM17 in SH-SY5Y human neuroblastoma cells.
Meng P; Yoshida H; Matsumiya T; Imaizumi T; Tanji K; Xing F; Hayakari R; Dempoya J; Tatsuta T; Aizawa-Yashiro T; Mimura J; Kosaka K; Itoh K; Satoh K
Neurosci Res; 2013 Feb; 75(2):94-102. PubMed ID: 23257508
[TBL] [Abstract][Full Text] [Related]
28. Amyloid precursor protein drives down-regulation of mitochondrial oxidative phosphorylation independent of amyloid beta.
Lopez Sanchez MIG; Waugh HS; Tsatsanis A; Wong BX; Crowston JG; Duce JA; Trounce IA
Sci Rep; 2017 Aug; 7(1):9835. PubMed ID: 28852095
[TBL] [Abstract][Full Text] [Related]
29. Localization and Processing of the Amyloid-β Protein Precursor in Mitochondria-Associated Membranes.
Del Prete D; Suski JM; Oulès B; Debayle D; Gay AS; Lacas-Gervais S; Bussiere R; Bauer C; Pinton P; Paterlini-Bréchot P; Wieckowski MR; Checler F; Chami M
J Alzheimers Dis; 2017; 55(4):1549-1570. PubMed ID: 27911326
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effects of curcumin on H
Song XJ; Zhou HY; Sun YX; Huang HC
Mol Biol Rep; 2020 Mar; 47(3):2047-2059. PubMed ID: 32036572
[TBL] [Abstract][Full Text] [Related]
31. Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease.
Steiner H; Capell A; Leimer U; Haass C
Eur Arch Psychiatry Clin Neurosci; 1999; 249(6):266-70. PubMed ID: 10653281
[TBL] [Abstract][Full Text] [Related]
32. Increased Foxo3a Nuclear Translocation and Activity is an Early Neuronal Response to βγ-Secretase-Mediated Processing of the Amyloid-β Protein Precursor: Utility of an AβPP-GAL4 Reporter Assay.
Law BM; Guest AL; Pullen MWJ; Perkinton MS; Williams RJ
J Alzheimers Dis; 2018; 61(2):673-688. PubMed ID: 29254083
[TBL] [Abstract][Full Text] [Related]
33. Caffeine, Through Adenosine A3 Receptor-Mediated Actions, Suppresses Amyloid-β Protein Precursor Internalization and Amyloid-β Generation.
Li S; Geiger NH; Soliman ML; Hui L; Geiger JD; Chen X
J Alzheimers Dis; 2015; 47(1):73-83. PubMed ID: 26402756
[TBL] [Abstract][Full Text] [Related]
34. A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ.
Kwart D; Gregg A; Scheckel C; Murphy EA; Paquet D; Duffield M; Fak J; Olsen O; Darnell RB; Tessier-Lavigne M
Neuron; 2019 Oct; 104(2):256-270.e5. PubMed ID: 31416668
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of Alzheimer's Disease Amyloid-β Protein Precursor in Astrocytes Both in vitro and in vivo.
Liang Y; Raven F; Ward JF; Zhen S; Zhang S; Sun H; Miller SJ; Choi SH; Tanzi RE; Zhang C
J Alzheimers Dis; 2020; 76(3):1071-1082. PubMed ID: 32597805
[TBL] [Abstract][Full Text] [Related]
36. New BACE1 Chimeric Peptide Inhibitors Selectively Prevent AβPP-β Cleavage Decreasing Amyloid-β Production and Accumulation in Alzheimer's Disease Models.
Resende R; Ferreira-Marques M; Moreira P; Coimbra JRM; Baptista SJ; Isidoro C; Salvador JAR; Dinis TCP; Pereira CF; Santos AE
J Alzheimers Dis; 2020; 76(4):1317-1337. PubMed ID: 32597812
[TBL] [Abstract][Full Text] [Related]
37. Novel presenilin 1 and 2 double knock-out cell line for in vitro validation of PSEN1 and PSEN2 mutations.
Pimenova AA; Goate AM
Neurobiol Dis; 2020 May; 138():104785. PubMed ID: 32032730
[TBL] [Abstract][Full Text] [Related]
38. Dissociation between the processivity and total activity of γ-secretase: implications for the mechanism of Alzheimer's disease-causing presenilin mutations.
Quintero-Monzon O; Martin MM; Fernandez MA; Cappello CA; Krzysiak AJ; Osenkowski P; Wolfe MS
Biochemistry; 2011 Oct; 50(42):9023-35. PubMed ID: 21919498
[TBL] [Abstract][Full Text] [Related]
39. The histidine composition of the amyloid-β domain, but not the E1 copper binding domain, modulates β-secretase processing of amyloid-β protein precursor in Alzheimer's disease.
Gough M; Blanthorn-Hazell S; Parkin ET
J Alzheimers Dis; 2015; 43(4):1163-8. PubMed ID: 25171714
[TBL] [Abstract][Full Text] [Related]
40. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
